Last year after the present Sanofi's new CEO joined the board from GSK, Sanofi has been aggressively into Mergers and Acquisitions, now another big giant to look for is Bayer for long time Bayer has been into active patent portfolio management and out licensing but as we have new CEO on board we have many mergers and acquisition awaiting from Bayer's end.
....................................................................................
Yesterday I was reading some analyst report in which they have mentioned about some companies for which venture capitalists have high hopes, they include the following
-RXi Pharmaceuticals Corporation (Nasdaq: RXII): RXi's proprietary sd-rxRNA molecules has a unique 'self delivery' property.
-Northwest Bio therapeutics (OTC BB: NWBO.OB): Northwest Bio therapeutics' vaccine to combat brain cancer
-Dendreon Corporation's (NASDAQ: DNDN): Dendreon announced recently that their drug Provenge for treatment for prostate cancer has been approved by FDA.
Successful Mergers and acquisitions can lead to market blockbusters like Lipitor, Erbitux and so on..Lets hope for the rest turn out to be best!!!!
ReplyDelete